|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500096108 |
|
最近更新日期: Date of Last Refreshed on: |
2025-01-17 14:26:54 |
|
注册时间: Date of Registration: |
2025-01-17 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
综合认知数字疗法对骨科疾病合并认知障碍患者康复结局的前瞻性、多中心真实世界队列研究 |
|
Public title: |
Integrated Cognitive Digital Therapy for the Rehabilitation Outcomes of Patients with Orthopedic Diseases and Cognitive Impairment: A Prospective, Multicenter Real-World Cohort Study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
综合认知数字疗法对骨科疾病合并认知障碍患者康复结局的前瞻性、多中心真实世界队列研究 |
|
Scientific title: |
Integrated Cognitive Digital Therapy for the Rehabilitation Outcomes of Patients with Orthopedic Diseases and Cognitive Impairment: A Prospective, Multicenter Real-World Cohort Study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
马颖宏 |
研究负责人: |
吴新宝 |
|
Applicant: |
MaYinghong |
Study leader: |
Wu Xinbao |
|
申请注册联系人电话: Applicant telephone: |
+86 136 6108 1260 |
研究负责人电话:
Study leader's |
+86 139 1008 4939 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
myh666@pku.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
jstliting@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市西城区新街口东街31号(新街口院区) |
研究负责人通讯地址: |
北京市西城区新街口东街31号(新街口院区) |
|
Applicant address: |
31 Xinjiekou East Street, Xicheng District, Beijing |
Study leader's address: |
31 Xinjiekou East Street, Xicheng District, Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
100035 |
研究负责人邮政编码: Study leader's postcode: |
100035 |
|
申请人所在单位: |
首都医科大学附属北京积水潭医院 |
||
|
Applicant's institution: |
Beijing Jishuitan Hospital, Capital Medical University |
||
|
研究负责人所在单位: |
首都医科大学附属北京积水潭医院 |
||
|
Affiliation of the Leader: |
Beijing Jishuitan Hospital, Capital Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
积伦[K2024]第[527]号-00 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
首都医科大学附属北京积水潭医院伦理审查委员会 |
||
|
Name of the ethic committee: |
Ethics Committee (seal) of Beijing Jishuitan Hospital, Capital Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-12-17 00:00:00 | ||
|
伦理委员会联系人: |
王娜 |
||
|
Contact Name of the ethic committee: |
Wang Na |
||
|
伦理委员会联系地址: |
首都医科大学附属北京积水潭医院新街口院区北楼四层,北京市西城区新街口东街31号 |
||
|
Contact Address of the ethic committee: |
4th floor, North-Building, 31 Xinjiekou East Street, Xicheng District, Beijing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 10 5851 7080 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
首都医科大学附属北京积水潭医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Beijing Jishuitan Hospital, Capital Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
首都医科大学附属北京积水潭医院新街口院区,北京市西城区新街口东街31号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
31 Xinjiekou East Street, Xicheng District, Beijing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
北京市科技计划项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
Beijing Municipal Science and Technology Project |
||||||||||||||||||||||
|
研究疾病: |
认知功能障碍 |
||||||||||||||||||||||
|
Target disease: |
Cognitive impairment |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
通过建立一个多中心、大规模、长期随访的骨科疾病合并认知障碍队列: 1.探索综合认知数字疗法在骨科疾病合并认知障碍患者中的临床改善效果(包括认知功能、日常生活能力及心理状态变化等); 2.通过长期大样本纵向随访,研究骨科疾病与认知障碍疾病的交互作用情况,评估该群体患者认知障碍疾病进程,探索骨科共患认知障碍疾病的干预方向。 |
||||||||||||||||||||||
|
Objectives of Study: |
By establishing a multicenter, large-scale, long-term follow-up cohort of orthopedic diseases combined with cognitive impairment: 1. Explore the clinical improvement effects of comprehensive cognitive digital therapy in patients with orthopedic diseases combined with cognitive impairment (including changes in cognitive function, daily living ability, and psychological state, etc.); 2. Through long-term large-sample longitudinal follow-up, study the interaction between orthopedic diseases and cognitive impairment diseases, assess the disease progression of cognitive impairment in this group of patients, and explore the intervention direction for orthopedic comorbid cognitive impairment diseases. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.有明确诊断的骨科疾病; 2.成人(>=18 周岁)蒙特利尔认知评估量表(MoCA)<26 分;儿童青少年(6~17 周岁)在干扰控制、冲突抑 制、空间知觉、记忆广度、加工速度、情景记忆、空间工作记忆、选择性注意、持续性注意、工作记忆和集中性注意认知功能中,任意一项功能分值<90 分(根据常模归类为较弱)。 3.同意接受认知功能测评 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Have a clearly diagnosed orthopedic disease; 2. Adult (>=18 years old) Montreal Cognitive Assessment Scale (MoCA) <26 points; Children and adolescents (6~17 years old) are in the process of interference control and conflict suppression system, spatial perception, memory span, processing speed, episodic memory, spatial working memory, selective attention, sustained attention, working memory, and concentrated attention, any one of the functional functions is scored < 90 points (classified as weak according to norms). 3. Agree to be assessed on cognitive function |
||||||||||||||||||||||
|
排除标准: |
1. 因视力、听力、失语、利手无法使用等问题不能完成认知功能测评; 2.研究者认为不适合参与试验者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Unable to complete the cognitive function assessment due to problems such as vision, hearing, aphasia, and inability to use the hand; 2. Those who are considered unsuitable to participate in the trial by the investigator. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-01-29 00:00:00至 To 2026-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-01-29 00:00:00 至 To 2026-09-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Electronic Data Capture, EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |